# Cardiovascular Systems partners with Innova Vascular on thrombectomy devices

Cardiovascular Systems Inc. (CSI) has partnered with Innova Vascular Inc. to develop and commercialize a full line of thrombectomy devices for treating peripheral vascular disease, deep vein thrombosis and pulmonary embolism. CSI intends to acquire and commercialize the devices pending regulatory clearance.

- Type: Partnership
- Announced: 2022-04-21
- Where: United States
- Status: announced
- Products: thrombectomy devices, manual aspiration devices, clot retrieval devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cardiovascular Systems](https://endata.com/companies/53965.md) (partner)
- [Innova Vascular](https://endata.com/companies/61447.md) (partner)

## Sources

- [mpo-mag.com](https://www.mpo-mag.com/breaking-news/cardiovascular-systems-innova-vascular-partner-on-thrombectomy-device-development/), 2022-04-21: "Cardiovascular Systems Inc. (CSI) is teaming up with Innova Vascular Inc. (Innova) to develop a full line of thrombectomy devices."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.